Fernando Contreras Mejia (Fernando Contreras)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Sentinel Lymph Node

Metastatic Colorectal Cancer

Top Venues

Revista colombiana de obstetricia y ginecologia

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Marc Edy Pierre, Ray Antonio Manneh Kopp, Abraham Hernández, Juliana Lucía Rodríguez-Castillo, Angélica Viviana Fletcher Prieto, Heydi M Ramírez, Oscar M Niño, Diego A Gómez, Daniel Eduardo Sanabria, Fernando Contreras Mejia, José R Pieschacón, Pedro Hernando Calderón Quiroz
Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer Revista colombiana de obstetricia y ginecologia 75 (1) (2024)
Marc Edy Pierre, Ray Antonio Manneh Kopp, Abraham Hernández, Juliana Lucía Rodríguez-Castillo, Angélica Viviana Fletcher Prieto, Heydi M Ramírez, Oscar M Niño, Diego A Gómez, Daniel Eduardo Sanabria, Fernando Contreras Mejia, José R Pieschacón, Pedro Hernando Calderón Quiroz
Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer Revista colombiana de obstetricia y ginecologia 75 (1) (2024)
Shannon Neville Westin, Kathleen Moore, Hye Sook Chon, Jung-Yun Lee, Jessica Thomes Pepin, Michael Sundborg, Ayelet Shai, Joseph de la Garza, Shin Nishio, Michael A Gold, Ke Wang, Kristi McIntyre, Todd D Tillmanns, Stephanie V Blank, Ji-Hong Liu, Michael McCollum, Fernando Contreras Mejia, Tadaaki Nishikawa, Kathryn Pennington, Zoltan Novak, Andreia Cristina de Melo, Jalid Sehouli, Dagmara Klasa-Mazurkiewicz, Christos Papadimitriou, Marta Gil-Martin, Birute Brasiuniene, Conor Donnelly, Paula Michelle Del Rosario, Xiaochun Liu, Els Van Nieuwenhuysen, null null
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)